Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.51 |
| ▸ | MEN1 | O00255 | 2/20 | 0.51 |
| ▸ | MAPT | P10636 | 2/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | USP2 | O75604 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | THRB | P10828 | 1/20 | 0.51 |
| ▸ | GAA | P10253 | 3/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | PGR | P06401 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | CA9 | Q16790 | 2/20 | 0.33 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.31 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.31 |
| ▸ | MAOB | P27338 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13222422 | 0.89 | L3MBTL1 (0.50) | L3MBTL1MEN1MAPTKMT2AUSP2 | |
| SCHEMBL7253428 | 0.89 | MEN1 (0.63) | L3MBTL1MEN1MAPTKMT2AUSP2 | |
| SCHEMBL8942786 | 0.86 | MAPT (0.59) | L3MBTL1MEN1MAPTKMT2AUSP2 | |
| SCHEMBL8868764 | 0.73 | MAPT (0.42) | L3MBTL1MEN1MAPTKMT2AUSP2 | |
| SCHEMBL7253897 | 0.70 | ALDH1A1 (0.55) | L3MBTL1MEN1MAPTKMT2AUSP2 | |
| SCHEMBL7251612 | 0.70 | GAA (0.46) | L3MBTL1MEN1MAPTKMT2APOLB | |
| Iodide SCHEMBL4956536 | 0.68 | GAA (0.45) | L3MBTL1MEN1MAPTKMT2APOLB | |
| SCHEMBL14355197 | 0.68 | MEN1 (0.53) | L3MBTL1MEN1MAPTKMT2AUSP2 | |
| SCHEMBL19461996 | 0.68 | KDM4E (0.43) | L3MBTL1MEN1MAPTKMT2AUSP2 | |
| SCHEMBL13566466 | 0.68 | PON1 (0.32) | L3MBTL1MEN1MAPTKMT2AUSP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12036208-B2 | Methods for treating neurodegenerative disorders | ALZHEON, INC. (US) | 2024-07-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12036208-B2 | Methods for treating neurodegenerative disorders | NLN, CLN6, SNCA | L3MBTL1 2001/4885MEN1 4000/4885MAPT 9/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.